P021 A phase 3, open-label study of tezacaftor/ivacaftor (TEZ/IVA) therapy: interim analysis of pooled safety, and efficacy in patients homozygous for F508del-CFTR
| Autor: | Patrick A. Flume, H. Zhou, K. De Boeck, J. Lekstrom-Himes, Christopher Simard, Damian G. Downey, R. Fischer Biner, Caroline A. Owen |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Pulmonary and Respiratory Medicine
Oncology medicine.medical_specialty business.industry medicine.disease Interim analysis Cystic fibrosis Ivacaftor 03 medical and health sciences 0302 clinical medicine Open label study Internal medicine Pediatrics Perinatology and Child Health medicine Tezacaftor F508del cftr In patient 030212 general & internal medicine business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Journal of Cystic Fibrosis. 17:S64-S65 |
| ISSN: | 1569-1993 |
| DOI: | 10.1016/s1569-1993(18)30318-7 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect